# Early Detection Initiative for Pancreatic Cancer

> **NCT04662879** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Pancreatic Cancer Action Network** · enrollment: 8869 (actual)

## Conditions studied

- Hyperglycemia
- Diabetes Mellitus
- Pancreas Ductal Adenocarcinoma

## Interventions

- **OTHER:** Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- **OTHER:** Abdominal imaging

## Key facts

- **NCT ID:** NCT04662879
- **Lead sponsor:** Pancreatic Cancer Action Network
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-14
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 8869 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662879, "Early Detection Initiative for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04662879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
